AMERICAN SHARED HOSPITAL SERVICES Cost, Depreciation, Amortization and Depletion
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Cost, Depreciation, Amortization and Depletion of $1.34 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostDepreciationAmortizationAndDepletion · last filed 2026-08-13
- AMERICAN SHARED HOSPITAL SERVICES cost, depreciation, amortization and depletion for the quarter ending 2026-06-30 was $1.34M, a 10.42% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES cost, depreciation, amortization and depletion for the quarter ending 2026-03-31 was $1.29M, a 10.80% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES cost, depreciation, amortization and depletion for the quarter ending 2025-12-31 was $1.31M, a 20.65% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES cost, depreciation, amortization and depletion for the quarter ending 2025-09-30 was $1.44M, a 13.51% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES cost, depreciation, amortization and depletion for fiscal 2025 was $5.69M, a 6.20% decline from fiscal 2024.
- AMERICAN SHARED HOSPITAL SERVICES cost, depreciation, amortization and depletion for fiscal 2024 was $6.07M, a 19.63% increase from fiscal 2023.
- AMERICAN SHARED HOSPITAL SERVICES cost, depreciation, amortization and depletion for fiscal 2023 was $5.07M, a 7.34% increase from fiscal 2022.
- AMERICAN SHARED HOSPITAL SERVICES cost, depreciation, amortization and depletion for fiscal 2022 was $4.73M, a 2.68% decline from fiscal 2021.
| Period end | Cost, Depreciation, Amortization and Depletion 3 month | Cost, Depreciation, Amortization and Depletion 6 month | Cost, Depreciation, Amortization and Depletion 9 month | Cost, Depreciation, Amortization and Depletion 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.34M 10-Q · filed 2026-08-13 | $2.63M 10-Q · filed 2026-08-13 | $3.94M derived: sum of 3 quarters · filed 2026-08-13 | $5.38M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $1.29M 10-Q · filed 2026-05-14 | $2.60M derived: sum of 2 quarters · filed 2026-05-14 | $4.04M derived: sum of 3 quarters · filed 2026-05-14 | $5.54M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $1.31M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-31 | $2.75M derived: sum of 2 quarters · filed 2026-03-31 | $4.25M derived: sum of 3 quarters · filed 2026-08-13 | $5.69M 10-K · filed 2026-03-31 |
| 2025-09-30 | $1.44M 10-Q/A · filed 2026-01-16 | $2.94M derived: sum of 2 quarters · filed 2026-08-13 | $4.38M 10-Q/A · filed 2026-01-16 | $6.03M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $1.50M 10-Q · filed 2026-08-13 | $2.94M 10-Q · filed 2026-08-13 | $4.59M derived: sum of 3 quarters · filed 2026-08-13 | $6.26M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $1.45M 10-Q · filed 2026-05-14 | $3.10M derived: sum of 2 quarters · filed 2026-05-14 | $4.76M derived: sum of 3 quarters · filed 2026-05-14 | $6.22M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $1.65M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-31 | $3.32M derived: sum of 2 quarters · filed 2026-03-31 | $4.77M derived: sum of 3 quarters · filed 2026-03-31 | $6.07M 10-K · filed 2026-03-31 |
| 2024-09-30 | $1.67M 10-Q/A · filed 2026-01-16 | $3.12M derived: sum of 2 quarters · filed 2026-01-16 | $4.42M 10-Q/A · filed 2026-01-16 | $5.68M derived: sum of 4 quarters · filed 2026-01-16 |
| 2024-06-30 | $1.46M 10-Q · filed 2025-08-13 | $2.75M 10-Q · filed 2025-08-13 | $4.01M derived: sum of 3 quarters · filed 2025-08-13 | $5.24M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $1.30M 10-Q · filed 2025-05-15 | $2.56M derived: sum of 2 quarters · filed 2025-05-15 | $3.79M derived: sum of 3 quarters · filed 2025-05-15 | $5.01M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $2.49M derived: sum of 2 quarters · filed 2025-04-04 | $3.72M derived: sum of 3 quarters · filed 2025-04-04 | $5.07M 10-K · filed 2025-04-04 |
| 2023-09-30 | $1.23M 10-Q · filed 2024-11-14 | $2.46M derived: sum of 2 quarters · filed 2024-11-14 | $3.81M 10-Q · filed 2024-11-14 | $5.02M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $1.23M 10-Q · filed 2024-08-14 | $2.58M 10-Q · filed 2024-08-14 | $3.80M derived: sum of 3 quarters · filed 2024-08-14 | $4.97M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $1.36M 10-Q · filed 2024-05-15 | $2.57M derived: sum of 2 quarters · filed 2024-05-15 | $3.74M derived: sum of 3 quarters · filed 2024-05-15 | $4.90M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $2.38M derived: sum of 2 quarters · filed 2024-04-01 | $3.54M derived: sum of 3 quarters · filed 2024-04-01 | $4.73M 10-K · filed 2024-04-01 |
| 2022-09-30 | $1.17M 10-Q · filed 2023-11-14 | $2.33M derived: sum of 2 quarters · filed 2023-11-14 | $3.51M 10-Q · filed 2023-11-14 | $4.70M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $1.16M 10-Q · filed 2023-08-14 | $2.34M 10-Q · filed 2023-08-14 | $3.53M derived: sum of 3 quarters · filed 2023-08-14 | $4.76M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $1.19M 10-Q · filed 2023-05-12 | $2.38M derived: sum of 2 quarters · filed 2023-05-12 | $3.60M derived: sum of 3 quarters · filed 2023-05-12 | $4.84M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $2.41M derived: sum of 2 quarters · filed 2023-03-31 | $3.66M derived: sum of 3 quarters · filed 2023-03-31 | $4.86M 10-K · filed 2023-03-31 |
| 2021-09-30 | $1.22M 10-Q · filed 2022-11-10 | $2.47M derived: sum of 2 quarters · filed 2022-11-10 | $3.67M 10-Q · filed 2022-11-10 | $5.35M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $1.24M 10-Q · filed 2022-08-15 | $2.44M 10-Q · filed 2022-08-15 | $4.13M derived: sum of 3 quarters · filed 2022-08-15 | $5.95M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $1.20M 10-Q · filed 2022-05-12 | $2.88M derived: sum of 2 quarters · filed 2022-05-12 | $4.70M derived: sum of 3 quarters · filed 2022-05-12 | $6.34M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $3.50M derived: sum of 2 quarters · filed 2022-03-30 | $5.14M derived: sum of 3 quarters · filed 2022-03-30 | $6.79M 10-K · filed 2022-03-30 |
| 2020-09-30 | $1.82M 10-Q · filed 2021-11-10 | $3.46M derived: sum of 2 quarters · filed 2021-11-10 | $5.10M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $1.64M 10-Q · filed 2021-08-12 | $3.28M 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |